Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium HFA BAI Dose-Ranging Study in COPD
NCT02203474Phase 2Withdrawn
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Teva Pharmaceutical Industries Ltd.. Planned start Aug 2014; status: withdrawn.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02203474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203474.